FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

385517000: Fondaparinux sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459696014 Fondaparinux sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1479722014 Fondaparinux sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3197861000005119 fondaparinuxnatrium da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fondaparinux sodium (substance) Is a Coagulation factor Xa inhibitor true Inferred relationship Some
Fondaparinux sodium (substance) Is a Direct acting anticoagulant (substance) false Inferred relationship Some
Fondaparinux sodium (substance) Is a Fondaparinux (substance) false Inferred relationship Some
Fondaparinux sodium (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Coagulation factor Xa inhibitor true Inferred relationship Some
Fondaparinux sodium (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Fondaparinux (substance) true Inferred relationship Some
Fondaparinux sodium (substance) Is a Oligosaccharide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
fondaparinuxnatrium 5 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
Product containing fondaparinux (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
Fondaparinux sodium 2.5mg/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
fondaparinuxnatrium 2,5 mg i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
fondaparinuxnatrium 12,5 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
fondaparinuxnatrium 12,5 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
fondaparinuxnatrium 12,5 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
fondaparinuxnatrium 2,5 mg i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
Product containing fondaparinux sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fondaparinux sodium (substance) Inferred relationship Some
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 5 milligram/0.4 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 7.5 milligram/0.6 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fondaparinux sodium (substance) Inferred relationship Some 1
Product containing precisely fondaparinux sodium 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fondaparinux sodium (substance) Inferred relationship Some 1
Fondaparinux sodium 5 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fondaparinux sodium (substance) Inferred relationship Some 1
Fondaparinux sodium 5 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Fondaparinux sodium (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start